STXS vs VANI: stock comparison and AI forecast
Stereotaxis, Inc. (STXS) and Vivani Medical, Inc. (VANI) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
STXS Stereotaxis, Inc.
- Market Cap
- $105M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
VANI Vivani Medical, Inc.
- Market Cap
- $95M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- STXS is 1.1 times larger than VANI by market capitalization ($105M against $95M).
- Both companies share the SEC industry classification Electromedical & Electrotherapeutic Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | STXS | VANI |
|---|---|---|
| Market Cap | $105M | $95M |
| P/B Ratio | – | 4.99x |
| EPS | $-0.25 | $-0.38 |
| Book Value/Share | – | $0.21 |
| Revenue/Share | $0.30 | – |
| FCF/Share | $-0.15 | $-0.29 |
Profitability & Margins
| Metric | STXS | VANI |
|---|---|---|
| ROE | – | -138.7% |
| ROA | – | -63.2% |
| ROIC | – | -77.8% |
| Gross Margin | 55.3% | – |
| Operating Margin | -75.3% | – |
| EBT Margin | -75.3% | – |
| Tax Rate | – | -0.0% |
Financial Health
| Metric | STXS | VANI |
|---|---|---|
| Current Ratio | 1.42x | 3.25x |
| Quick Ratio | 0.95x | – |
| D/E Ratio | – | 1.20x |
| Financial Leverage | – | 2.20x |
| Interest Coverage | -45.7x | -1164.2x |
| Working Capital | $11M | $15M |
Cash Flow
| Metric | STXS | VANI |
|---|---|---|
| Operating Cash Flow | -$15M | -$25M |
| Free Cash Flow | -$16M | -$26M |
| Capital Spending | -$210K | -$1M |
| FCF/Sales | -51.6% | – |
| CapEx/Sales | 0.7% | – |
Operational Efficiency
| Metric | STXS | VANI |
|---|---|---|
| Receivables Turnover | 4.0x | – |
| Inventory Turnover | 1.1x | – |
| Fixed Assets Turnover | 10.4x | – |
| Days Sales Outstanding | 92 days | – |
| Days Inventory | 342 days | – |
| Payables Period | 188 days | – |
| Cash Conversion Cycle | 246 days | – |
Income Statement
| Metric | STXS | VANI |
|---|---|---|
| Total Revenue | $30M | – |
| Operating Income | -$23M | -$27M |
| Net Income | – | -$26M |
| R&D Expense | $10M | $18M |
| SG&A Expense | $46M | – |
| Cost of Goods Sold | $13M | – |
Dividend & Shareholder Information
| Metric | STXS | VANI |
|---|---|---|
| Shares Outstanding | 100M | 90M |
STXS vs VANI: stock comparison and AI forecast
Which is bigger, STXS or VANI?
STXS is 1.1 times larger than VANI by market capitalization ($105M against $95M).
Which one does Intratio's AI model rank higher, STXS or VANI?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.